Clinical trial
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1…
NCT00481390 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00481390 |
|---|---|
| Title | Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients |
| Official title | Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection, HIV-1 Infection |
| Intervention type | Procedure |
| Interventions | Cheek cells sample, Blood sample |
| Enrollment | 1,110 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 1, 2007 |
| Last update posted | Jun 8, 2011 |
| Countries | Finland, Ireland, Netherlands, Portugal, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: